(-)-Indolactam V is a protein kinase C (PKC) activator with antitumor activity; it dose-dependently affects multiple human embryonic stem cell (hESC) lines (e.g., HUES2, HUES4, HUES8); it upregulates mRNA levels of pancreatic developmental markers including Pdx1, HNF6, PTF1A, SOX9, HB9, and PROX1; it functions in both mouse and human cells to promote signals involved in pancreatic development.